Pfizer 2024 Full-Year Financial Guidance December 2023

Pfizer presented full-year 2024 financial guidance on December 13, 2023, covering operating and financial performance projections, product pipeline developments, and strategic initiatives including the Seagen acquisition. The presentation includes forward-looking statements on revenue, earnings growth, regulatory approvals, and commercial performance across its pharmaceutical and vaccine portfolio.